LENZ — Lenz Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $441.49m
- $228.21m
- 35
- 20
- 89
- 45
Annual cashflow statement for Lenz Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.109 | -68.4 | -70.8 | -101 | -125 |
| Depreciation | |||||
| Non-Cash Items | 0.08 | 57.8 | 19.7 | 17.9 | 71.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.01 | 1.71 | -2.5 | -7.21 | -39.2 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.019 | -8.72 | -52.9 | -88 | -90 |
| Capital Expenditures | 0 | -1.54 | -5.74 | -6.59 | -10.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -235 | 237 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -1.54 | -5.74 | -242 | 226 |
| Financing Cash Flow Items | — | — | — | -0.079 | -0.067 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 30.1 | 417 | 0.597 | 0.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.019 | 19.8 | 359 | -329 | 137 |